Central Trust Company’s Transmedics TMDX Stock Holding History

Central Trust Company’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.7K	Hold	550	–	–	﹤0.01%	827
2025 Q4	$66.9K	Hold	550	–	–	﹤0.01%	762
2025 Q3	$61.7K	Hold	550	–	–	﹤0.01%	779
2025 Q2	$73.7K	Sell	550 -200	-27%	-$22K	﹤0.01%	728
2025 Q1	$50.5K	Sell	750 -692	-48%	-$47.6K	﹤0.01%	792
2024 Q4	$89.9K	Buy	1,442 +892	+162%	+$83K	﹤0.01%	676
2024 Q3	$86.3K	Hold	550	–	–	﹤0.01%	676
2024 Q2	$82.8K	Hold	550	–	–	﹤0.01%	688
2024 Q1	$40.7K	Hold	550	–	–	﹤0.01%	841
2023 Q4	$43.4K	Hold	550	–	–	﹤0.01%	819
2023 Q3	$30.1K	Hold	550	–	–	﹤0.01%	872
2023 Q2	$46.2K	Hold	550	–	–	﹤0.01%	791
2023 Q1	$41.7K	Hold	550	–	–	﹤0.01%	817
2022 Q4	$33.9K	Hold	550	–	–	﹤0.01%	839
2022 Q3	$23K	Hold	550	–	–	﹤0.01%	915
2022 Q2	$17K	Buy	550 +50	+10%	+$1.33K	﹤0.01%	957
2022 Q1	$13K	Hold	500	–	–	﹤0.01%	1045
2021 Q4	$10K	Hold	500	–	–	﹤0.01%	1062
2021 Q3	$17K	Hold	500	–	–	﹤0.01%	948
2021 Q2	$17K	Hold	500	–	–	﹤0.01%	914
2021 Q1	$21K	Hold	500	–	–	﹤0.01%	827
2020 Q4	$10K	Hold	500	–	–	﹤0.01%	896
2020 Q3	$7K	Hold	500	–	–	﹤0.01%	905
2020 Q2	$9K	Hold	500	–	–	﹤0.01%	853
2020 Q1	$6K	Buy	+500	New	+$8.38K	﹤0.01%	963

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Central Trust Company's TMDX Position: Q1 2026 in Review

Central Trust Company held its Transmedics (TMDX) position steady in Q1 2026 at 550 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Central Trust Company first reported a position in TMDX in Q1 2020 and has held it in 25 quarters since. The position peaked at $89.9K in Q4 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Central Trust Company held 550 shares of Transmedics worth $54.7K as of Q1 2026.
Central Trust Company left its Transmedics share count unchanged in Q1 2026.
Transmedics made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #827 holding.
Central Trust Company first reported a position in Transmedics in Q1 2020 and has held it in 25 quarters since.
Central Trust Company's Transmedics position peaked at $89.9K in Q4 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.